Life science companies face a unique challenge: communicating complex science and uncertain timelines to investors who need clear information to make decisions. SwedenBIO’s updated Industry standard for information disclosure in life science capital raising helps simplify this process. This session explores how better disclosure creates stronger investor relationships and a more robust capital market.
During an intense hour we will cover:
What life science investors really want to know
Three investors unveil the critical gaps they see in most company presentations.
What you should be able to tell investors
Why SwedenBIO’s updated Industry standard for information disclosure in life science capital raising is needed and how it should be used.
What regulations require you to disclose
Get an overview of mandatory disclosure requirements and recent regulatory updates.
Discussion: From investor expectations to company reality
Investors and company leaders discuss building confidence while managing uncertainty.
Info about registration will come soon.
